Although STAT1 has long been considered to be a tumour suppressor by promoting HNSCC cell death [10], recent reports show that STAT1 activation also mediates programmed cell death ligand 1 (PD-L1) expression in HNSCC cells thereby promoting tumour immunosuppression [13, 14]. This evidence concerns the gene STAT1 and head and neck squamous cell carcinoma.